Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

SuperCom Ltd. (NASDAQ: SPCB) EM Tracking Increasingly Seen as Key to Successfully Addressing Domestic Violence

Posted on November 26, 2024 by MissionIR
  • Two incidents of domestic violence-related homicides in Maine help illustrate the importance of court-administered electronic monitoring programs for staving off violence between domestic partners after relationships break down
  • With a track record of over 50 governments and 100,000 individuals served, SuperCom is innovating advanced electronic monitoring (“EM”) solutions to establish safeguards for potential victims
  • SuperCom’s solution uses GPS technology to track the movements of domestic violence defendants, helping prevent further violence while also alerting law enforcement and potential victims if court-imposed boundaries are trespassed

Electronic monitoring technology developer SuperCom (NASDAQ: SPCB) provides products and services that help clients track people under their supervision. Its solutions are primarily used by police and court agencies to monitor the movements of individuals released pretrial, on probation after conviction, or on parole following incarceration.

Concerns about the incidence of domestic violence are increasingly leading to the use of EM monitoring for individuals accused of such crimes. A U.S. Department of Justice grant to research the use of EM in domestic violence cases in two locations, published in 2004, found that the use of radio frequency (“RF”) devices to track domestic violence defendants and protect potential victims was received by the victims as “useful enhancements to their safety” (https://ibn.fm/rWaLA).

Nevertheless, the application of EM in helping to protect potential domestic violence victims is far from universal.

A recent news report on two instances of domestic violence-related homicides in Maine noted that electronic monitoring is only available for pretrial inmates in nine of the state’s 16 counties and is only used sparingly in all but two of those counties. According to the report, counties that don’t use EM say that bad cell reception and tight staffing make GPS monitoring challenging and many sheriffs say it’s too expensive (https://ibn.fm/9NxOU).

The fathers of the two homicide victims pointed to electronic monitoring as a solution that could have saved their daughters’ lives and have taken on an advocacy role in seeking wider use of the technology.

SuperCom’s mission has been to make its PureSecurity EM platform available to agencies throughout the United States and Europe to enhance public safety efforts. The company was founded in 1988 and has served over 50 governments and 100,000 individuals.

The company’s leadership has announced several new contracts in the United States and Europe during the past year, many of them related to domestic violence monitoring.

“If you put someone on house arrest, you’re saving 90% of the costs, direct costs,” SuperCom President and CEO Ordan Trabelsi said during a recent appearance at micro-cap conference platform LD Micro’s 17th annual invitational event (https://ibn.fm/N1Luk). “We won a $32 million project in Romania. Not only is that a substantial new project because Romania’s never done this before — and we’re talking about 15,000 offenders that we would be monitoring at any given point over the course of six years — but it also gives us a strong reference for any other projects around the world of similar size.”

SuperCom’s GPS technology is packaged in a sleek, waterproof design that improves on the bulky ankle monitors worn in other programs. It has a battery life of up to one year, eliminating the need for continuous daily recharging with an electrical source, and it is unobtrusive, allowing defendants to continue working and functioning in society without being stigmatized by obvious devices.

The platform’s advanced technology tracks the defendants’ location in real-time, including their elevation (for in-building details), while also relating to the location of participating victims, notifying the victim and local authorities about any incidents of trespassing the boundaries established by the law enforcement agencies.

SuperCom provides 24/7 monitoring services to support agencies in various programs, including inmate monitoring within prisons, rehabilitation initiatives, and substance abuse monitoring for individuals prohibited from consuming alcohol.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SuperCom Ltd. SPCB | Leave a comment

SuperCom Ltd. (NASDAQ: SPCB) Conference Presentation Focuses on Lives Saved Through EM Technology and Services

Posted on November 25, 2024 by MissionIR
  • SuperCom is an electronic monitoring (“EM”) innovator helping to establish public safety and well-being through the use of advanced technology and monitoring services for government clients that make increasing use of supervised-release programs
  • During a recent investor presentation at the annual LD Micro Invitational, SuperCom’s president and CEO, Ordan Trabelsi, outlined the company’s services and critical benefits to clientele, along with the company’s corresponding success with over 50 governments and 100,000 individuals served
  • SuperCom anticipates that its $32 million contract in Romania, largely focused on monitoring domestic violence offenders, will help boost its credibility with other European governments running monitoring programs of a similar nature

Governments worldwide are turning to electronic monitoring (“EM”) solutions as a means of sustaining public safety and reducing repeat criminal behavior while also reducing the costs associated with imprisoning individuals — a trend outlined by EM innovator SuperCom (NASDAQ: SPCB) at a recent investor LD Micro presentation. SuperCom President and CEO Ordan Trabelsi explained the competitive edge of the company’s GPS-enabled PureSecurity platform, among a narrow field of rivals, during his appearance at LD Micro’s 17th annual invitational on Oct. 30 (https://ibn.fm/XPMXE). Trabelsi participated in one-on-one interviews with potential investors over the course of the event’s three days in Southern California.

SuperCom was founded in 1988 and has a track record of serving over 50 governments and 100,000 individuals. Its CAGR is above 60%, with 73% recurring revenue and a five-year EBITDA of $4.8 million as of last year.

“Our run-rate this year is even higher. We had a run-rate of at least $7.2 million EBITDA,” Trabelsi said.

SuperCom’s end-to-end solution provides a developed GPS technology for reliable offender tracking and 24/7 monitoring services to give criminal justice clients the confidence they need to operate supervised-release programs that allow select individuals to remain free from incarceration, potentially productive at their jobs and homes, at a fraction of incarceration costs.

“Over half a percent of the U.S. is in prison. That’s a very high rate; certainly not effective, not cost-effective, and not effective in terms of increasing public safety. … If you put someone on house arrest, you’re saving 90% of the costs, direct costs,” Trabelsi said. “And that’s just a sign that we need to improve things in the U.S., and also in other areas of the world, there’s room for improvement.”

SuperCom’s strategy is particularly focused on domestic violence cases in which any specifically identified victims or potential victims, as well as the authorities, can be notified by smartphone of the offender’s proximity before any physical danger arises.

“(It’s) one of the things that we in SuperCom are leaders in the world. We probably have more units in domestic violence than any other player out there,” Trabelsi said at the LD Micro event.

The technology is an improvement over bulky ankle monitors, offering instead a sleek, waterproof device that can be worn unobtrusively without drawing attention from other people. It has a battery life of up to one year, eliminating the need for continuous daily recharging with an electrical source.

SuperCom currently provides services in California’s large EM market and many other parts of Europe and the United States.

“We won a $32 million project in Romania,” Trabelsi said. “Not only is that a substantial project because Romania’s never done this before — and we’re talking about 15,000 offenders that we would be monitoring at any given point over the course of six years — but it also gives us a strong reference for any other projects around the world of similar size.”

The company’s services also include inmate monitoring in prisons, rehabilitation services and substance abuse monitoring — continuously evaluating a monitored subject’s alcohol intake through sweat-sensitive sensors, for example — and Trabelsi noted the company’s technology could work well for other services as well, although the company’s small size has led its officers to limit their focus to the most profitable opportunities at the moment.

“Our solutions create positive social impact and improve public safety worldwide,” Trabelsi said. “We see this over and over in various regions. We’re helping with saving the lives of potential victims. We’re aiding in eradicating domestic violence. We’re increasing public safety and well-being.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SuperCom Ltd. SPCB | Leave a comment

Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression

Posted on November 25, 2024 by MissionIR
  • The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, targeting cancer drug resistance and immune suppression.
  • Kairos Pharma’s lead candidate ENV-105 is an antibody targeting CD105, a protein identified as a key driver of resistance to various cancer treatments.
  • ENV-105 is in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646, in combination with Apalutamide) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110, in combination with Osimertinib).
  • The company is working with PreCheck Health Services to develop companion biomarkers for ENV-105, with the aim of identifying patients who will benefit most from being administered the drug candidate.
  • Kairos is uniquely positioned to capitalize on the immunotherapy market, expected to reach $148 billion by 2030, as well as on the $11.3 billion prostate cancer market and the $14 billion EGFR-driven lung cancer market.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, is dedicated to advancing innovative oncology therapies to overcome critical challenges in cancer drug resistance and immune suppression, two significant challenges to effective cancer treatment. With an extensive intellectual property portfolio valid until 2035 to 2040, the company is developing a notable pipeline of drugs tackling cancer drug resistance with a focus on overcoming impacting widespread cancers, including prostate and lung cancer, as well as reversing immune suppression.

Kairos Pharma’s pipeline includes multiple candidates in different clinical and preclinical stages:

  • ENV-105: An antibody that targets CD105 — a protein identified as a key driver of resistance to various cancer treatments, this lead candidate is currently in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646 in combination with Apalutamide to overcome anti-androgen resistance) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110 in combination with Osimertinib to address resistance).
  • KROS-201: In the preclinical stage with preparation for a Phase 1 trial, this drug candidate targets glioblastoma and works by activating external T cells to target and destroy tumor cells. This candidate has received Investigational New Drug (“IND”) clearance from the Food and Drug Administration.
  • KROS-101: In the preclinical stage, this drug candidate is designed to complement existing immunotherapies, showing promise in enhancing the immune system’s response by increasing the number and efficiency of T cells.
  • KROS-102: In the preclinical stage, this drug candidate targets autoimmune diseases and works by decreasing T cell activity.
  • KROS-301 and KROS-401: In the preclinical stage, both of these candidates focus on inhibiting cancer cell growth and tackling immune suppression in cancers such as triple-negative breast cancer.
  • ENV-205: In the preclinical stage, this antibody targets Mitochondrial DNA with the goal of reversing resistance to chemotherapy in prostate cancer and others.

To achieve more accurate patient screening and monitoring for the ENV-105 Phase 1 and Phase 2 clinical trials, the company recently sealed a strategic agreement with PreCheck Health Services Inc., a CLIA-certified and CAP-accredited clinical laboratory specializing in genetic sequencing (https://ibn.fm/66UsY).

Under the terms of the partnership, PreCheck Health will focus on developing companion biomarkers for ENV-105, with the aim of advancing cancer treatment by identifying patients who will benefit most from being administered Kairos’s drug candidate. The two companies will utilize advanced molecular diagnostics to corroborate and further develop biomarkers previously identified in a Phase 2 clinical trial, with the goal of predicting patient responses to ENV-105 prior to treatment, in order to offer a more personalized approach to cancer care. The collaboration will rely on PreCheck’s proprietary SolidTumorCheck+ platform, which allows for gene expression profiling of tumor biopsies.

“This collaboration is an exciting step forward for Kairos Pharma. By working with PreCheck Health Services, we are advancing our mission to provide personalized cancer treatment solutions,” said Dr. John Yu, Kairos Pharma’s CEO. “The biomarkers we develop will enable us to tailor therapies to individual patients, improving their chances of a successful response to ENV105.”

The company also attended two major industry events in October, to discuss its drug development efforts and extensive pipeline. First, Dr. Yu participated in a fireside chat at the 2024 Maxim Healthcare Virtual Summit where he spoke with Jason McCarthy, Ph.D., Senior Managing Director, Head of Biotechnology Research at Maxim Group (https://ibn.fm/UxaE7). The summit was held virtually on Oct. 15 – 17. The Kairos Pharma CEO also presented a corporate overview at the LD Micro Main Event XVII, held on Oct. 28 – 30 in Los Angeles (https://ibn.fm/pnQmM).

With its innovative technologies to reverse key mechanisms of drug resistance and immune suppression of cancer and addressing underserved areas in cancer treatment, Kairos Pharma is strongly positioned to capitalize on the cancer therapy and immunotherapy markets by meeting substantial unmet needs. With ENV-105 in particular, the company has significant potential to capture a portion of the prostate cancer market, estimated at $11.3 billion, and the EGFR-driven lung cancer market, valued at $14 billion. The immunotherapy market, estimated to reach up to $148 billion by 2030, represents another major growth area for Kairos Pharma.

For more information, visit the company’s website at www.KairosPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to KAPA are available in the company’s newsroom at https://ibn.fm/KAPA

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Kairos Pharma Ltd. KAPA | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical and Strategic Updates

Posted on November 25, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for advancing neurodegenerative therapies in 2025.

To view the full press release, visit https://ibn.fm/2Ib9D

About Annovis Bio Inc.

Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer’s and Parkinson’s. The company is developing innovative therapies that target multiple neurotoxic proteins, with the goal of restoring brain function and improving the quality of life for patients.

For more information, visit the company’s website at www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Annovis Bio Inc. ANVS | Leave a comment

MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reports Strong Financial Performance and New Contracts, Expanding Footprint in US and Israel

Posted on November 25, 2024 by MissionIR

SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New York, underscore SuperCom’s expanding presence in public safety and rehabilitative services. CEO Ordan Trabelsi highlighted SuperCom’s operational efficiency and growth potential, as demonstrated by improved profitability, positive free cash flow, and an increased gross profit margin. The company remains focused on innovation and deepening client relationships to fuel continued growth.

To view the full press release, visit https://ibn.fm/NxXAh

About SuperCom

Since 1988, SuperCom has been a global provider of traditional and digital identity solutions, providing advanced safety, identification, and security solutions to governments and organizations, both private and public, worldwide. Through its proprietary e-Government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has inspired governments and national agencies to design and issue secure Multi-ID documents and robust digital identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one field-proven RFID & mobile technology and product suite, accompanied by advanced complementary services for various industries, including healthcare and homecare, security and safety, community public safety, law enforcement, electronic monitoring, and domestic violence prevention. For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SuperCom Ltd. SPCB | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Advances Quantum Computing with Enhanced 4,400+ Qubit Advantage2(TM) Processor

Posted on November 22, 2024 by MissionIR
  • The successful calibration and benchmarking of the 4,400+ qubits Advantage2 processor is a significant milestone in D-Wave’s ongoing development of its sixth-generation annealing quantum computing system.
  • Advantage2 has significantly more computational power than the current Advantage(TM) system, able to solve certain customer problems 25,000 times faster.
  • Advantage2 offers improvements in areas such as faster time-to-solution, higher quality solutions, and ability to solve larger problems.

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has achieved a significant milestone in the ongoing development of its sixth-generation annealing quantum computing system by completing the calibration and benchmarking of a 4,400+ qubit Advantage2 processor (https://ibn.fm/SEoTd).

The Advantage2 processor has shown substantial performance gains, with more computational power than the current 5,000 qubit Advantage system, as demonstrated by recent performance benchmarks. Advantage2 has been able to solve a wide range of complex computational problems in areas such as optimization, artificial intelligence (“AI”) and materials science, in some cases 25,000 times faster than the current Advantage system.

To emphasize its capabilities across a wide range of quantum applications, the processor can also provide five times better solutions on problems that require advanced precision and was able to surpass the current Advantage system in 99% of tests on satisfiability problems.

The 4,400+ qubits Advantage2 processor can deliver significant improvements in the following areas:

  • Qubit coherence time: doubled in comparison with the Advantage processor, which drives faster time to solution,
  • Energy scale: increased by 40% to deliver higher-quality solutions,
  • Qubit connectivity: increased from 15 to 20-way connectivity to enable solutions to larger problems.

“Our strategic decision to focus development efforts on enhancing the connectivity and coherence of our next annealing quantum computing system has proven successful,” said Dr. Trevor Lanting, chief development officer at D-Wave. “We’re thrilled with the performance of our recently calibrated processor, and we believe this technology will deliver amazing results for our customers, solving bigger and more complex problems.”

For more information, visit the company’s website at www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

AI is Helping to Ease the Job Application Process

Posted on November 22, 2024 by MissionIR

Several companies are touting novel artificial intelligence technologies that promise to revolutionize the job-search process. This development has emerged at a time when the rate at which people are looking for new jobs has reached very high levels. For example, data reveals that at least 28% of U.S. residents were recently job-hunting.

Jeff, a well-followed TikTok user, emphasized that as hiring managers incorporated more AI functions in the hiring process, applicants also need to go the extra mile in order to stand a chance of being hired. In his videos, Jeff walks viewers through the AI-backed processes. He adds that he was able to get a job after using AI to formulate his applications, practice how to respond to interview questions and make meaningful connections with potential employers.

Chantal Cowie, another ardent believer in the utility of AI tools in the job-search process, recently shared how helpful AI can be during a job hunt. She reveals that AI saved her precious time because she had a hectic 60-hour week schedule. By automating aspects of the job search with AI, she was able to save plenty of time. Cowie says AI helped her to apply to a lot more jobs and advance further than had been previously possible in the rounds of interviews for each role. She secured a six-figure position that is fully remote as a result of leveraging AI tools.

As AI becomes increasingly popular in the job search process, many platforms have emerged to serve individuals who need help in landing a suitable and rewarding job. AI Hawk, Simplify and LazyApply are examples of platforms catering to this need. AI Hawk has a bold claim indicating that those who use their services have an 80% higher likelihood of landing a role in comparison to those who don’t use the service.

As these tools proliferate, some critics say the risk of errors and hallucination is high and users could be disadvantaged by the use of AI in the job search process. Others say automation erodes authenticity and could even disadvantage employers since they may select an individual whose application documents were embellished by AI.

Those concerns notwithstanding, the use of AI in everyday life activities is growing. The companies behind those AI tools could be basking in the limelight of their innovations, but behind this revolution lies several unsung heroes; including metals like gold and copper making it possible for AI components like chips and data centers to be built. Companies such as McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), leveraging their expertise to help address the surging demand for those minerals, are well-positioned to capitalize on the rise of AI.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Nine-Month Financial Results and Business Update

Posted on November 22, 2024 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices division, released its financial results for the nine months ending Sept. 30, 2024. The announcement highlights the company’s progress in advancing its I&I-focused pipeline and the expansion of its CDMO operations, showcasing its commitment to delivering high-quality biologics and fostering strategic partnerships. This update reflects Scinai’s efforts to strengthen its position in the biopharmaceutical and CDMO markets, aligning with its broader vision of growth and innovation.

To view the full press release, visit https://ibn.fm/9fakk

About Scinai Immunotherapeutics Ltd.

Scinai is a biopharmaceutical company with two complementary business units. One is focused on in-house development of inflammation and immunology (“I&I”) biological therapeutic products beginning with an innovative, de-risked pipeline of nanosized VHH antibodies (“NanoAbs”) targeting diseases with large unmet medical needs. The second business unit is a boutique CDMO providing biological drug development, analytical methods development, clinical GMP manufacturing, and preclinical and clinical trial design and execution services to early stage biotech companies. For more information, visit the company’s website at www.Scinai.com.

NOTE TO INVESTORS: The latest news and updates relating to SCNI are available in the company’s newsroom at https://ibn.fm/SCNI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights American-Made Battery Production at Fullerton Facility

Posted on November 21, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, provided an update on its Fullerton, California, battery operations, which focus on producing next-generation battery packs and modules domestically. This initiative supports Mullen’s commitment to zero emissions and reducing reliance on imported battery components. CEO and Chairman David Michery emphasized the company’s mission to transition to American-made battery technology as part of its broader sustainability goals.

To view the full press release, visit https://ibn.fm/lOH7m

About Mullen Automotive Inc.

Mullen Automotive is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with two United States-based vehicle plants located in Tunica, Mississippi, (120,000 square feet) and Mishawaka, Indiana (650,000 square feet). In August 2023, Mullen began commercial vehicle production in Tunica. In September 2023, Mullen received IRS approval for federal EV tax credits on its commercial vehicles with a Qualified Manufacturer designation that offers eligible customers up to $7,500 per vehicle. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. The CARB-issued HVIP approval on the Mullen THREE, Class 3 EV truck, provides up to a $45,000 cash voucher at time of vehicle purchase. The company has also recently expanded its commercial dealer network to seven dealers with the addition of Papé Kenworth. Other previously announced dealers include Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key Midwest, West Coast, Pacific Northwest, New England and Mid-Atlantic markets. The company has also announced Foreign Trade Zone (“FTZ”) status approval for its Tunica, Mississippi, commercial vehicle manufacturing center. FTZ approval provides a number of benefits, including deferment of duties owed and elimination of duties on exported vehicles. For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised for Opportunity Amid Rising Demand for ‘AI Metals’

Posted on November 20, 2024 by MissionIR

McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the evolution of artificial intelligence (“AI”), spotlighting Geoffrey Hinton’s (“the Godfather of AI”) award of the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind AI as we know it today. The piece describes early work and systems compared to modern capabilities, showcasing significant requirements for current AI systems in terms of hardware such as microchips.

“Critical metals like copper, silver and gold have consequently seen rising demand to supply the rapidly growing AI industry,” the article reads. “Opportunities are being created, and numerous companies like McEwen Mining (NYSE: MUX) (TSX: MUX) are positioned to reap the rewards of addressing this demand for ‘AI metals.’”

To view the full article, visit https://ibn.fm/cg8Aw

About McEwen Mining Inc.
McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, it owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, MUX’s chairman and chief owner, has personally provided the company with $220 million and takes an annual salary of $1.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in McEwen Mining Inc. MUX | Leave a comment